デフォルト表紙
市場調査レポート
商品コード
1668147

動物用バイオマーカー市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、製品タイプ別、用途別、疾患タイプ別、地域別、競合別、2020～2030年

Veterinary Biomarkers Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type, By Product Type, By Application, By Disease Type, By Region, & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
動物用バイオマーカー市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、製品タイプ別、用途別、疾患タイプ別、地域別、競合別、2020～2030年
出版日: 2025年02月28日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

動物用バイオマーカーの世界市場規模は2024年に9億6,553万米ドルで、予測期間のCAGRは12.30%で2030年まで目覚ましい成長が予測されています。

動物用バイオマーカーの世界市場とは、動物用ヘルスケア産業において、病気の診断、動物の健康状態のモニタリング、動物の治療効果の評価にバイオマーカーを使用する分野を指します。バイオマーカーとは、タンパク質、遺伝子、代謝物などの測定可能な指標であり、動物の様々な生理学的・病理学的プロセスを検出・定量化するために使用されます。

市場概要
予測期間 2026～2030年
市場規模：2024年 9億6,553万米ドル
市場規模：2030年 19億4,086万米ドル
CAGR：2025～2030年 12.30%
急成長セグメント コンパニオンアニマル
最大市場 北米

市場促進要因

動物疾病および人獣共通感染症の流行増加

主な市場課題

バリデーションと標準化

主な市場動向

ポイントオブケア診断の台頭

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用バイオマーカー市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 動物タイプ別（コンパニオンアニマル、生産動物）
    • 製品タイプ別（バイオマーカー、キットと試薬、バイオマーカーリーダー）
    • 用途別（疾患診断、前臨床研究、その他）
    • 疾患タイプ別（炎症性および感染症、心血管疾患、骨格筋疾患、腫瘍、その他）
    • 地域別
    • 企業別（2024年）
  • 製品市場マップ
    • 動物タイプ別
    • 製品タイプ別
    • 用途別
    • 疾患タイプ別
    • 地域別

第6章 北米の動物用バイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の動物用バイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の動物用バイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の動物用バイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの動物用バイオマーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Zoetis Inc.
  • Virbac SA
  • Life Diagnostics Inc
  • Acuvet Biotech
  • Merck & Co., Inc.
  • IDEXX Laboratories, Inc.
  • Mercodia AB
  • Antech Diagnostics Inc

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 17609

Global Veterinary Biomarkers Market was valued at USD 965.53 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.30% through 2030. The Global Veterinary Biomarkers Market refers to the sector within the veterinary healthcare industry that deals with the use of biomarkers for diagnosing diseases, monitoring animal health, and assessing treatment efficacy in animals. Biomarkers are measurable indicators, such as proteins, genes, or metabolites, that can be used to detect and quantify various physiological and pathological processes in animals.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 965.53 Million
Market Size 2030USD 1940.86 Million
CAGR 2025-203012.30%
Fastest Growing SegmentCompanion Animals
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Animal Diseases and Zoonotic Infections

The rising prevalence of animal diseases and zoonotic infections is a critical factor driving the growth of the Global Medical Scheduling Software Market. Globally, zoonotic diseases account for approximately one billion illness cases and millions of fatalities annually. Zoonoses comprise 60% of all newly emerging infectious diseases, underscoring their significant public health impact. Over the past 30 years, more than 30 novel human pathogens have been identified, with 75% originating from animals, highlighting the critical need for enhanced disease surveillance, veterinary healthcare advancements, and cross-sectoral collaboration to mitigate the risks of animal-to-human transmission. As veterinary clinics, hospitals, research centers, and government agencies strive to manage the increasing burden of infectious and chronic diseases in animals, the demand for efficient appointment scheduling, resource allocation, and workflow optimization is escalating. Below is an in-depth analysis of how the growing incidence of animal-related diseases is fueling the expansion of medical scheduling software in the veterinary and broader healthcare sectors.

Key Market Challenges

Validation and Standardization

Validating and standardizing biomarker assays for veterinary use is essential for ensuring accuracy and reliability. Establishing consistent standards and methodologies is challenging due to the diversity of animal species, breeds, and health conditions. This lack of standardization can hinder the widespread adoption of biomarker-based diagnostics and treatments.

Key Market Trends

Rise of Point-of-Care Diagnostics

Point-of-care diagnostics are revolutionizing veterinary medicine by providing rapid and on-site testing capabilities. These portable and user-friendly devices allow veterinarians to perform biomarker-based tests right in the clinic, enabling quicker diagnoses and immediate treatment decisions. The convenience of point-of-care testing is expected to drive its adoption in veterinary practices.

Key Market Players

  • Zoetis Inc.
  • Virbac SA
  • Life Diagnostics Inc
  • Acuvet Biotech
  • Merck & Co., Inc.
  • IDEXX Laboratories, Inc.
  • Mercodia AB
  • Antech Diagnostics Inc

Report Scope:

In this report, the Global Veterinary Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Biomarkers Market, By Animal Type:

  • Companion Animals
  • Production Animals

Veterinary Biomarkers Market, By Product Type:

  • Biomarkers
  • Kits & Reagents
  • Biomarker Readers

Veterinary Biomarkers Market, By Application:

  • Disease Diagnostics
  • Preclinical Research
  • Others

Veterinary Biomarkers Market, By Disease Type:

  • Inflammatory & Infectious Diseases
  • Cardiovascular Diseases
  • Skeletal Muscle Diseases
  • Tumor
  • Others

Veterinary Biomarkers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Biomarkers Market.

Available Customizations:

Global Veterinary Biomarkers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Biomarkers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Companion Animals, Production Animals)
    • 5.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 5.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 5.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Animal Type
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By Disease Type
    • 5.3.5. By Region

6. North America Veterinary Biomarkers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 6.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 6.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 6.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Biomarkers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Disease Type
    • 6.3.2. Canada Veterinary Biomarkers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Disease Type
    • 6.3.3. Mexico Veterinary Biomarkers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Disease Type

7. Europe Veterinary Biomarkers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 7.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 7.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 7.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Biomarkers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Disease Type
    • 7.3.2. United Kingdom Veterinary Biomarkers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Disease Type
    • 7.3.3. France Veterinary Biomarkers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Disease Type
    • 7.3.4. Italy Veterinary Biomarkers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Disease Type
    • 7.3.5. Spain Veterinary Biomarkers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Disease Type

8. Asia-Pacific Veterinary Biomarkers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 8.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 8.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 8.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Biomarkers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Disease Type
    • 8.3.2. Japan Veterinary Biomarkers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Disease Type
    • 8.3.3. India Veterinary Biomarkers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Disease Type
    • 8.3.4. Australia Veterinary Biomarkers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Disease Type
    • 8.3.5. South Korea Veterinary Biomarkers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Disease Type

9. South America Veterinary Biomarkers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 9.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 9.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 9.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Biomarkers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Disease Type
    • 9.3.2. Argentina Veterinary Biomarkers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Disease Type
    • 9.3.3. Colombia Veterinary Biomarkers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Disease Type

10. Middle East and Africa Veterinary Biomarkers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 10.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 10.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 10.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Biomarkers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Disease Type
    • 10.3.2. Saudi Arabia Veterinary Biomarkers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Disease Type
    • 10.3.3. UAE Veterinary Biomarkers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Disease Type
    • 10.3.4. Kuwait Veterinary Biomarkers Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Animal Type
        • 10.3.4.2.2. By Product Type
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Zoetis Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Virbac SA
  • 14.3. Life Diagnostics Inc
  • 14.4. Acuvet Biotech
  • 14.5. Merck & Co., Inc.
  • 14.6. IDEXX Laboratories, Inc.
  • 14.7. Mercodia AB
  • 14.8. Antech Diagnostics Inc

15. Strategic Recommendations

16. About Us & Disclaimer